167 related articles for article (PubMed ID: 22035437)
1. Psoriatic arthritis - treatment update.
Mease PJ
Bull NYU Hosp Jt Dis; 2011; 69(3):243-9. PubMed ID: 22035437
[No Abstract] [Full Text] [Related]
2. Investigational agents for rheumatoid arthritis.
Merkel PA; Letourneau EN; Polisson RP
Rheum Dis Clin North Am; 1995 Aug; 21(3):779-96. PubMed ID: 8619099
[TBL] [Abstract][Full Text] [Related]
3. [Revised recommendations of the Deutsche Gesellschaft für Rheumatologie on therapy with tumor necrosis factor-inhibiting active substances on inflammatory diseases].
Manger B;
Z Rheumatol; 2002 Dec; 61(6):694-7. PubMed ID: 12491133
[No Abstract] [Full Text] [Related]
4. Guideline for anti-TNF-alpha therapy in psoriatic arthritis.
Kyle S; Chandler D; Griffiths CE; Helliwell P; Lewis J; McInnes I; Oliver S; Symmons D; McHugh N;
Rheumatology (Oxford); 2005 Mar; 44(3):390-7. PubMed ID: 15695305
[No Abstract] [Full Text] [Related]
5. [Psoriasis and psoriatic rheumatism: effectiveness of etanercept for cutaneous and joint lesions].
Paul C; Solignac M
Ann Dermatol Venereol; 2010 Apr; 137(4 Suppl):13-5. PubMed ID: 20510165
[No Abstract] [Full Text] [Related]
6. [The off-label-prescription of TNF-alpha blocking agents for spondyloarthropathies in the context of recent statement by a German federal court].
Sieper J
Z Rheumatol; 2002 Dec; 61(6):688-93. PubMed ID: 12491132
[TBL] [Abstract][Full Text] [Related]
7. Psoriatic arthritis, methotrexate and the liver--are rheumatologists putting their patients at risk?
Lindsay K; Gough A
Rheumatology (Oxford); 2008 Jul; 47(7):939-41. PubMed ID: 18474510
[No Abstract] [Full Text] [Related]
8. Psoriatic arthritis: current concepts on pathogenesis-oriented therapeutic options.
Turkiewicz AM; Moreland LW
Arthritis Rheum; 2007 Apr; 56(4):1051-66. PubMed ID: 17393414
[No Abstract] [Full Text] [Related]
9. Psoriatic arthritis treatment: biological response modifiers.
Mease PJ; Antoni CE
Ann Rheum Dis; 2005 Mar; 64 Suppl 2(Suppl 2):ii78-82. PubMed ID: 15708944
[TBL] [Abstract][Full Text] [Related]
10. Current concepts and new developments in the treatment of psoriatic arthritis.
Pipitone N; Kingsley GH; Manzo A; Scott DL; Pitzalis C
Rheumatology (Oxford); 2003 Oct; 42(10):1138-48. PubMed ID: 12810935
[TBL] [Abstract][Full Text] [Related]
11. [Psoriatic arthritis: what the dermatologist needs to know, Part 2].
López-Ferrer A; Torrente-Segarra V; Puig L
Actas Dermosifiliogr; 2010 Nov; 101(9):742-8. PubMed ID: 21034704
[TBL] [Abstract][Full Text] [Related]
12. The role of methotrexate in psoriatic arthritis: what is the evidence?
Ianculescu I; Weisman MH
Clin Exp Rheumatol; 2015; 33(5 Suppl 93):S94-7. PubMed ID: 26470718
[TBL] [Abstract][Full Text] [Related]
13. New GRAPPA and EULAR recommendations for the management of psoriatic arthritis.
Coates LC; Gossec L; Ramiro S; Mease P; van der Heijde D; Smolen JS; Ritchlin C; Kavanaugh A
Rheumatology (Oxford); 2017 Aug; 56(8):1251-1253. PubMed ID: 28077693
[No Abstract] [Full Text] [Related]
14. [Therapy of psoriasis vulgaris and psoriatic arthritis with etanercept].
Mrowietz U; Barth J; Boehncke WH; Rosenbach T; Wozel G
J Dtsch Dermatol Ges; 2005 Jun; 3(6):470-2. PubMed ID: 15892851
[No Abstract] [Full Text] [Related]
15. Efficacy and tolerability of anti-tumour necrosis factor therapy in psoriatic arthritis patients: results from the South Swedish Arthritis Treatment Group register.
Kristensen LE; Gülfe A; Saxne T; Geborek P
Ann Rheum Dis; 2008 Mar; 67(3):364-9. PubMed ID: 17644547
[TBL] [Abstract][Full Text] [Related]
16. Extensive and severe CNS demyelination associated with golimumab therapy.
Maillart E; Papeix C; Mellerio C; Bertrand A; Lubetzki C; Louapre C
J Neurol; 2016 Sep; 263(9):1869-71. PubMed ID: 27456211
[No Abstract] [Full Text] [Related]
17. Termination of disease modifying antirheumatic drugs in psoriatic arthritis.
Lacaille D; Stein HB; Raboud J; Klinkhoff AV
J Rheumatol; 2002 Apr; 29(4):860-1. PubMed ID: 11950038
[No Abstract] [Full Text] [Related]
18. Effectiveness and retention rates of methotrexate in psoriatic arthritis in comparison with methotrexate-treated patients with rheumatoid arthritis.
Lie E; van der Heijde D; Uhlig T; Heiberg MS; Koldingsnes W; Rødevand E; Kaufmann C; Mikkelsen K; Kvien TK
Ann Rheum Dis; 2010 Apr; 69(4):671-6. PubMed ID: 19740904
[TBL] [Abstract][Full Text] [Related]
19. [Recommendations on the management of psoriatic arthritis].
Passeron T; Goupille P; Boulinguez S
Ann Dermatol Venereol; 2011 Jun; 138(6 Suppl 1):H10-2. PubMed ID: 21703468
[No Abstract] [Full Text] [Related]
20. [Psoriatic arthritis (PsA)].
Behrens F
Krankenpfl J; 2004; 42(5-6):180. PubMed ID: 15527240
[No Abstract] [Full Text] [Related]
[Next] [New Search]
